摘要
Abstract
Objective To explore the clinical effect of sodium nitroprusside,milrinone,and levosimendan in the treatment of patients with acute heart failure.Methods The clinical data of 150 patients with acute heart failure treated at our hospital from January,2014 to December,2015 were retrospectively analyzed.The patients were divided into group A,group B,and group C,50 cases for each group.Group A were treated with sodium nitroprusside,group B milrinone,and group C levosimendan.The mortality,second hospitalization rate,treatment effect,incidence of cardiovascular complications,and N-terminal pro-brain natriuretic peptide content change were compared between these three groups before and after the treatment.Results The mortality,second hospitalization rate,treatment effect,incidence of cardiovascular complications,and N-terminal pro-brain natriuretic peptide content change were better in group C than in group A and group B,with statistical differences (P＜0.05).Conclusion Levosimendan in the treatment of patients with acute heart failure is significantly effective,so it is worth being clinically generalized.关键词
左西孟旦/米利农/硝普钠/急性心力衰竭Key words
Levosimendan/Milrinone/Sodium nitroprusside/Acute heart failure
